These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7076611)

  • 21. After empiric therapy: what to do until the granulocyte comes back.
    Pizzo PA
    Rev Infect Dis; 1987; 9(1):214-9. PubMed ID: 3547574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Episodes of fever in the agranulocytic phase of the treatment of acute myeloblastic leukemia in adults].
    Bernard JF; Renoux M; Boivin P
    Sem Hop; 1976 Jan; 52(2):111-3. PubMed ID: 185700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Empiric antibiotic therapy with an amikacin-carbenicillin-cefoxitin combination in granulocytopenic febrile patients--a clinical report.
    Fernández-Rañada J; Fernández-Garese D; Caretti D; Vázquez L; Escudero A; Olmeda F
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):511-3. PubMed ID: 6642788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.
    Schimpff SC; Gaya H; Klastersky J; Tattersall MH; Zinner SH
    J Infect Dis; 1978 Jan; 137(1):14-29. PubMed ID: 624850
    [No Abstract]   [Full Text] [Related]  

  • 25. Empiric antibiotic therapy for granulocytopenic patients.
    Schimpff SC
    Bull N Y Acad Med; 1982 Nov; 58(8):750-6. PubMed ID: 6963185
    [No Abstract]   [Full Text] [Related]  

  • 26. The results of a randomized trial of empirical antibiotic treatment in febrile neutropenic patients with four beta-lactam/aminoglycoside combinations.
    Hann I; Noone P; Prentice HG; Sage R; Blacklock H; Stirling L; Gray R; Corringham R; Boesen E; Mohiuddin J
    J Antimicrob Chemother; 1983 May; 11 Suppl C():57-63. PubMed ID: 6352605
    [No Abstract]   [Full Text] [Related]  

  • 27. Empiric antimicrobial therapy in the febrile granulocytopenic patient.
    Hughes WT
    Infect Control Hosp Epidemiol; 1990 Mar; 11(3):151-6. PubMed ID: 2179402
    [No Abstract]   [Full Text] [Related]  

  • 28. Fever in the patient with cancer. Pathophysiology and the initial evaluation and management.
    Gutiérrez-Nuñez JJ
    Bol Asoc Med P R; 1984 Jun; 76(6):256-64. PubMed ID: 6380516
    [No Abstract]   [Full Text] [Related]  

  • 29. Traditional empiric antibiotic treatment is still effective for neonatal fever.
    Kristal M; Dor V; Glikman D
    Acta Paediatr; 2017 Nov; 106(11):1885-1886. PubMed ID: 28692184
    [No Abstract]   [Full Text] [Related]  

  • 30. Can antibacterial therapy be discontinued in persistently febrile granulocytopenic cancer patients?
    Joshi JH; Schimpff SC; Tenney JH; Newman KA; de Jongh CA
    Am J Med; 1984 Mar; 76(3):450-7. PubMed ID: 6702875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients].
    Sampi K; Kumai R; Maseki N; Sakurai M; Kaneko Y; Hattori M
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):674-9. PubMed ID: 3469935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of infection in myelosuppressed patients: clinical trials and common sense.
    Greene WH
    Exp Hematol; 1985; 13 Suppl 16():80-8. PubMed ID: 3987839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
    Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cefepime as an empiric treatment of febrile neutropenia in patients after high dose therapy and autologous stem cell transplantation].
    Zikesoá E; Hnátková M; Vacková B; Jedlicková A; Klener P; Trnený M
    Cas Lek Cesk; 2006; 145(5):383-6, 388-9. PubMed ID: 16755776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The febrile granulocytopenic patient in the intensive care unit.
    Walsh TJ
    Crit Care Clin; 1988 Apr; 4(2):259-80. PubMed ID: 3048587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amikacin plus ceftazidime versus amikacin plus piperacillin versus amikacin plus aztreonam in infections in neoplastic patients with granulocytopenia.
    Casali A; Ameglio F; Gionfra T; Tonachella R; Paoletti G; Gallo Curcio C
    Chemioterapia; 1987 Dec; 6(6):440-4. PubMed ID: 3325175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of a combination of cefotaxime, tobramycin and vancomycin as antibiotic therapy for neutropenia.
    Brunet F; Lanore JJ; Dhainaut JF; Dreyfus F; Huyghebaert MF; Varet B; Monsallier JF
    Drugs; 1988; 35 Suppl 2():195. PubMed ID: 3396480
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of antimicrobial synergism in infected granulocytopenic patients.
    Standiford HC; Johnson DE; Schimpff SC
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1007-10. PubMed ID: 6540682
    [No Abstract]   [Full Text] [Related]  

  • 39. Concept of empiric therapy with antibiotic combinations. Indications and limits.
    Klastersky J
    Am J Med; 1986 May; 80(5C):2-12. PubMed ID: 3521271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empirical antimicrobial therapy with Timentin plus amikacin in febrile granulocytopenic cancer patients.
    Meunier F; Snoeck R; Lagast H; Woussen F; Klastersky J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():195-201. PubMed ID: 3636334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.